Skip to search boxSkip to navigationSkip to main content

Insulin and glucose play a role in foam cell formation and function

  • Pavel N. Shashkin(corresponding author)
    ,
  • Nitin Jain
    ,
  • Yury I. Miller
    ,
  • Benjamin A. Rissing
    ,
  • Yuqing Huo
    ,
  • Susanna R. Keller
*Corresponding author for this work
  • University of Virginia
    ,
  • Cleveland Clinic Foundation
    ,
  • Pfizer
    ,
  • University of California at San Diego
    ,
  • University of Minnesota Twin Cities
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Background: Foam cell formation in diabetic patients often occurs in the presence of high insulin and glucose levels. To test whether hyperinsulinemic hyperglycemic conditions affect foam cell differentiation, we examined gene expression, cytokine production, and Akt phosphorylation in human monocyte-derived macrophages incubated with two types of oxidized low density lipoprotein (LDL), minimally modified LDL (mmLDL) and extensively oxidized LDL (OxLDL). Methods and results: Using Affymetrix GeneChip® arrays, we found that several genes directly related to insulin signaling were changed. The insulin receptor and glucose-6-phosphate dehydrogenase were upregulated by mmLDL and OxLDL, whereas insulin-induced gene I was significantly down-regulated. In hyperinsulinemic hyperglycemic conditions, modified LDL upregulated Akt phosphorylation and expression of the insulin-regulated aminopeptidase. The level of proinflammatory cytokines, IL-1β, IL-12, and IL-6, and of a 5-lipoxygenase eicosanoid, 5-hydroxyeicosatetraenoic acid (5-HETE), was also increased. Conclusion: These results suggest that the exposure of macrophages to modified low density lipoproteins in hyperglycemic hyperinsulinemic conditions affects insulin signaling and promotes the release of proinflammatory stimuli, such as cytokines and eicosanoids. These in turn may contribute to the development of insulin resistance.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Article number

13

Journal (Volume, Issue Number)

Cardiovascular Diabetology (Volume 5)

Publication milestones

  • Published - 06/20/2006

Publication status

Published - 06/20/2006

ISSN

1475-2840

Publication IDs

  • Scopus: 33747598913
  • PubMed: 16787541
  • ORCID: /0000-0002-0305-4122/work/124760183

Publication metrics

Metrics

SciVal
FWCI
0.75
SciVal
Author count
9
SciVal
citations
23
SciVal
Paper percentile
75
Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Social media
2
Citation count
27
Captures
25

Funding Details

FunderFunding number
NHLBI
P01HL055798